Availability of arsenic in human milk in women and its correlation with arsenic in urine of breastfed children living in arsenic contaminated areas in Bangladesh

Md Rafiqul Islam, John Attia, Mohammad Alauddin, Mark McEvoy, Patrick McElduff, Christine Slater, Md Monirul Islam, Ayesha Akhter, Catherine d'Este, Roseanne Peel, Shahnaz Akter, Wayne Smith, Stephen Begg, Abul Hasnat Milton, Md Rafiqul Islam, John Attia, Mohammad Alauddin, Mark McEvoy, Patrick McElduff, Christine Slater, Md Monirul Islam, Ayesha Akhter, Catherine d'Este, Roseanne Peel, Shahnaz Akter, Wayne Smith, Stephen Begg, Abul Hasnat Milton

Abstract

Background: Early life exposure to inorganic arsenic may be related to adverse health effects in later life. However, there are few data on postnatal arsenic exposure via human milk. In this study, we aimed to determine arsenic levels in human milk and the correlation between arsenic in human milk and arsenic in mothers and infants urine.

Methods: Between March 2011 and March 2012, this prospective study identified a total of 120 new mother-baby pairs from Kashiani (subdistrict), Bangladesh. Of these, 30 mothers were randomly selected for human milk samples at 1, 6 and 9 months post-natally; the same mother baby pairs were selected for urine sampling at 1 and 6 months. Twelve urine samples from these 30 mother baby pairs were randomly selected for arsenic speciation.

Results: Arsenic concentration in human milk was low and non-normally distributed. The median arsenic concentration in human milk at all three time points remained at 0.5 μg/L. In the mixed model estimates, arsenic concentration in human milk was non-significantly reduced by -0.035 μg/L (95% CI: -0.09 to 0.02) between 1 and 6 months and between 6 and 9 months. With the progression of time, arsenic concentration in infant's urine increased non-significantly by 0.13 μg/L (95% CI: -1.27 to 1.53). Arsenic in human milk at 1 and 6 months was not correlated with arsenic in the infant's urine at the same time points (r = -0.13 at 1 month and r = -0.09 at 6 month). Arsenite (AsIII), arsenate (AsV), monomethyl arsonic acid (MMA), dimethyl arsinic acid (DMA) and arsenobetaine (AsB) were the constituents of total urinary arsenic; DMA was the predominant arsenic metabolite in infant urine.

Conclusions: We observed a low arsenic concentration in human milk. The concentration was lower than the World Health Organization's maximum permissible limit (WHO Permissible Limit 15 μg/kg-bw/week). Our findings support the safety of breastfeeding even in arsenic contaminated areas.

Figures

Figure 1
Figure 1
Correlation between arsenic in breast milk and arsenic in urine of children at 1 month of children’s age.
Figure 2
Figure 2
Correlation between arsenic in breast milk and arsenic in urine of children at 6 month of children’s age.

References

    1. Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D, Hoque AM, Nermell B, Yunus M, Roy S, Persson LA, Arifeen SE, Moore S, Vahter M. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol Lett. 2009;185:197–202. doi: 10.1016/j.toxlet.2009.01.001.
    1. Argos M, Kalra T, Pierce BL, Chen Y, Parvez F, Islam T, Ahmed A, Hasan R, Hasan K, Sarwar G, Levy D, Slavkovich V, Graziano JH, Rathouz PJ, Ahsan H. A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh. Am J Epidemiol. 2011;174:185–194. doi: 10.1093/aje/kwr062.
    1. Tanya T. Is arsenic “lactation intolerant”? Study indicates low excretion in breast milk. Environ Health Perspect. 2008;116:A306.
    1. Mandal BK, Suzuki KT. Arsenic round the world: a review. Talanta. 2002;58:201–235. doi: 10.1016/S0039-9140(02)00268-0.
    1. Islam MR, Khan I, Hassan SMN, McEvoy M, D’Este C, Attia J, Peel R, Sultana M, Akter S, Milton AH. Association between type 2 diabetes and chronic arsenic exposure in drinking water: a cross sectional study in Bangladesh. Environ Heal. 2012;11:38. doi: 10.1186/1476-069X-11-38.
    1. Ahmed S, Ahsan KB, Kippler M, Mily A, Wagatsuma Y, Hoque AM, Ngom PT, El Arifeen S, Raqib R, M V. In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol Sci. 2012;129:305–314. doi: 10.1093/toxsci/kfs202.
    1. Fängström B, Moore S, Nermell B, Kuenstl L, Goessler W, Grandér M, Kabir I, Palm B, Arifeen SE, M V. Breast-feeding protects against arsenic exposure in Bangladeshi infants. Environ Health Perspect. 2008;116:963–969. doi: 10.1289/ehp.11094.
    1. Bentum JK, Sackitey OJ, Tuffuor JK, Essumang DK, Koranteng-Addo EJ, Owusu-Ansah E. Lead, Cadmium and Arsenic in breast milk of lactating mothers in Odumanse-Atua community in Manya Krobo district of eastern region of Ghana. J Chem Pharm Res. 2010;2:16–20.
    1. Boekelheide K, Blumberg B, Chapin RE, Cote I, Graziano JH, Janesick A, Lane R, Lillycrop K, Myatt L, States JC, Thayer KA, Waalkes MP, Rogers JM. Predicting later-life outcomes of early-life exposures. Environ Health Perspect. 2012;120:1353–1361. doi: 10.1289/ehp.1204934.
    1. Vahter M. Effects of arsenic on maternal and fetal health. Annu Rev Nutr. 2009;29:381–399. doi: 10.1146/annurev-nutr-080508-141102.
    1. Smith AH CMS. Health effects of arsenic and chromium in drinking water: recent human findings. Annu Rev Public Health. 2009;30:107–122. doi: 10.1146/annurev.publhealth.031308.100143.
    1. Hamadani JD, Tofail F, Nermell B, Gardner R, Shiraji S, Bottai M, Arifeen S,E, Huda SN, Vahter M. Critical windows of exposure for arsenic-associated impairment of cognitive function in pre-school girls and boys: a population-based cohort study. Int J Epidemiol. 2011;40:1593–1604. doi: 10.1093/ije/dyr176.
    1. Watanabe C, Inaoka T, Matsui T, Ishigaki K, Murayama N, R O. Effects of arsenic on younger generations. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2003;38:129–139. doi: 10.1081/ESE-120016885.
    1. Grandjean P, PJ L. Developmental neurotoxicity of industrial chemicals. Lancet. 2006;368:2167–2178. doi: 10.1016/S0140-6736(06)69665-7.
    1. Concha G, Vogler G, Lezcano D, Nermell B, M V. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci. 1998;44:185–190. doi: 10.1093/toxsci/44.2.185.
    1. Vahter M. Health effects of early life exposure to arsenic. Basic Clin Pharmacol Toxicol. 2008;102:204–211. doi: 10.1111/j.1742-7843.2007.00168.x.
    1. Samanta G, Das D, Mandal BK, Chowdhury TR, Chakraborti D, Pal A, Ahamed S. Arsenic in the breast milk of lactating women in arsenic-affected areas of West Bengal, India and its effect on infants. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2007;42:1815–1825. doi: 10.1080/10934520701566785.
    1. Vahter M. Mechanisms of arsenic biotransformation. Toxicology. 2002;181–182:211–217. doi: 10.1016/S0300-483X(02)00285-8.
    1. Tseng CH. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2007;25:1–22. doi: 10.1080/10590500701201695.
    1. IAEA . Stable isotope technique to assess intake of human milk in breastfed infants. In: IAEA, editor. IAEA Human Health Series. Vienna: IAEA; 2010.
    1. Smith AH, Lingas EO, Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ. 2000;78:1093–1103.
    1. American Public Health Association . Standard methods for the examination of water and wastewater. In: Greenberg AE, CLSEaton AD, editors. APHA-AWWA-WEF, 1995. 19. Washington D.C: American Public Health Association, American Water Works Association and Water Environment Federation; 1995.
    1. Concha G, Vogler G, Nermell B, Vahter M. Low-level arsenic excretion in breast milk of native Andean women exposed to high levels of arsenic in the drinking water. Int Arch Occup Environ Health. 1998;71:42–46. doi: 10.1007/s004200050248.
    1. Sternowsky HJ, Moser B, Szadkowsky D. Arsenic in breast milk during the first 3 months of lactation. Int J Hyg Environ Health. 2002;205:405–409. doi: 10.1078/1438-4639-00161.
    1. Gurbay A, Charehsaz M, Eken A, Sayal A, Girgin G, Yurdakok M, Yigit S, Erol DD, Sahin G, Aydin A. Toxic metals in breast milk samples from Ankara, Turkey: assessment of lead, cadmium, nickel, and arsenic levels. Biol Trace Elem Res. 2012;149:117–122. doi: 10.1007/s12011-012-9400-2.
    1. Chao HH, Guo CH, Huang CB, Chen PC, Li HC, Hsiung DY, Chou YK. Arsenic, cadmium, lead, and aluminium concentrations in human milk at early stages of lactation. Pediatr Neonatol. 2014;55:127–134. doi: 10.1016/j.pedneo.2013.08.005.
    1. Vahter M. Species differences in the metabolism of arsenic compounds. Appl Organomet Chem. 1994;8:175–182. doi: 10.1002/aoc.590080304.
    1. Buchet JP, Lauwerys R, Roels H. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int Arch Occup Environ Health. 1981;48:111–118. doi: 10.1007/BF00378431.
    1. Zeisel SH. The fetal origins of memory: the role of dietary choline in optimal brain development. J Pediatr. 2006;149:S131–S136. doi: 10.1016/j.jpeds.2006.06.065.
    1. Velzing-Aarts FV, Holm PI, Fokkema MR, van der Dijs FP, Ueland PM FAM. Plasma choline and betaine and their relation to plasma homocysteine in normal pregnancy. Am J Clin Nutr. 2005;81:1383–1389.
    1. Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, Parvez F, Chen Y, Levy D, Factor-Litvak P, Graziano JH. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr. 2006;84:1093–1101.
    1. Khambalia A, Latulippe ME, Campos C, Merlos C, Villalpando S, Picciano MF, Oc DL. Milk folate secretion is not impaired during iron deficiency in humans. J Nutr. 2006;136:2617–2624.
    1. Ilcol YO, Ozbek R, Hamurtekin E, Ulus IH. Choline status in newborns, infants, children, breast-feeding women, breast-fed infants and human breast milk. J Nutr Biochem. 2005;16:489–499. doi: 10.1016/j.jnutbio.2005.01.011.
    1. Liu Z, Carbrey J, Agre P, Rosen B. Arsenic trioxide uptake by human and rat aquaglyceroporinss. Biochem Biophys Res Commun. 2004;316:1178–1185. doi: 10.1016/j.bbrc.2004.03.003.
    1. Rosen BP. Biochemistry of arsenic detoxification. FEBS Lett. 2002;529:86–92. doi: 10.1016/S0014-5793(02)03186-1.
    1. Matsuzaki T, Machida N, Tajika Y, Ablimit A, Suzuki T, Aoki T, Hagiwara HKT. Expression and immunolocalization of water channel aquaporins in the rat and mouse mammry gland. Histochem Cell Biol. 2005;123:501–512. doi: 10.1007/s00418-005-0753-x.
    1. Bhattacharya S, Chatterjee S, Sarkar S. Pattern of arsenic exposure to children: new born to toddler stages. J Nat Sci Res. 2012;2:39–48.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever